Matches in SemOpenAlex for { <https://semopenalex.org/work/W3165377617> ?p ?o ?g. }
- W3165377617 endingPage "898" @default.
- W3165377617 startingPage "887" @default.
- W3165377617 abstract "The management of moderate-to-severe psoriasis has been transformed by the introduction of biological therapies. These medicines, particularly those targeting interleukin (IL)-17 and IL-23p19, can offer clear or nearly clear skin for the majority of patients with psoriasis, with good long-term drug survival. However, as currently used, none of these therapies is curative and disconcertingly there is a small but increasing number of patients with severe psoriasis who have failed all currently available therapeutic modalities. A similar scenario has occurred in other immune-mediated inflammatory diseases (IMIDs) where treatment options are limited in severely affected patients. In these cases, cell therapy, including haematopoietic stem cell transplantation (HSCT) and mesenchymal stromal cells (MSC), has been utilized. This review discusses the various forms of cell therapy currently available, their utility in the management of IMIDs and emerging evidence for efficacy in severe psoriasis that is unresponsive to biological therapy. Balancing the risks and benefits of treatment vs. the underlying disease is key; cell therapy carries significant risks, costs, regulation and other complexities, which must be justified by outcomes. Although HSCT has anecdotally been reported to benefit severe psoriasis, sometimes with apparent cure, this has mainly been in the setting of other coincidental ‘routine’ indications. In psoriasis, cell therapies, such as MSC and regulatory T cells, with a lower risk of complications are likely to be more appropriate. Well-designed controlled trials coupled with mechanistic studies are warranted if advanced cell therapies are to be developed and delivered as a realistic option for severe psoriasis." @default.
- W3165377617 created "2021-06-07" @default.
- W3165377617 creator A5025494836 @default.
- W3165377617 creator A5043680612 @default.
- W3165377617 creator A5078821076 @default.
- W3165377617 date "2021-07-27" @default.
- W3165377617 modified "2023-10-16" @default.
- W3165377617 title "The promise and challenges of cell therapy for psoriasis*" @default.
- W3165377617 cites W1505349275 @default.
- W3165377617 cites W1967581093 @default.
- W3165377617 cites W1988158895 @default.
- W3165377617 cites W1989791334 @default.
- W3165377617 cites W1996965660 @default.
- W3165377617 cites W1998207985 @default.
- W3165377617 cites W2002993815 @default.
- W3165377617 cites W2012096917 @default.
- W3165377617 cites W2017413267 @default.
- W3165377617 cites W2025919954 @default.
- W3165377617 cites W2031790029 @default.
- W3165377617 cites W2033641981 @default.
- W3165377617 cites W2036348189 @default.
- W3165377617 cites W2036452348 @default.
- W3165377617 cites W2041443103 @default.
- W3165377617 cites W2044695442 @default.
- W3165377617 cites W2044875340 @default.
- W3165377617 cites W2046496525 @default.
- W3165377617 cites W2048704264 @default.
- W3165377617 cites W2050201865 @default.
- W3165377617 cites W2051454588 @default.
- W3165377617 cites W2054037320 @default.
- W3165377617 cites W2059651841 @default.
- W3165377617 cites W2063140011 @default.
- W3165377617 cites W2064596041 @default.
- W3165377617 cites W2066122901 @default.
- W3165377617 cites W2080605737 @default.
- W3165377617 cites W2082586271 @default.
- W3165377617 cites W2085795043 @default.
- W3165377617 cites W2087152359 @default.
- W3165377617 cites W2088182504 @default.
- W3165377617 cites W2095666785 @default.
- W3165377617 cites W2099572412 @default.
- W3165377617 cites W2101215929 @default.
- W3165377617 cites W2104239016 @default.
- W3165377617 cites W2105151699 @default.
- W3165377617 cites W2107642756 @default.
- W3165377617 cites W2118922078 @default.
- W3165377617 cites W2121126920 @default.
- W3165377617 cites W2122822855 @default.
- W3165377617 cites W2125987139 @default.
- W3165377617 cites W2134864266 @default.
- W3165377617 cites W2142046859 @default.
- W3165377617 cites W2144232379 @default.
- W3165377617 cites W2146635373 @default.
- W3165377617 cites W2149209349 @default.
- W3165377617 cites W2149567581 @default.
- W3165377617 cites W2153389047 @default.
- W3165377617 cites W2159442019 @default.
- W3165377617 cites W2167235468 @default.
- W3165377617 cites W2173497140 @default.
- W3165377617 cites W2201227263 @default.
- W3165377617 cites W2337861353 @default.
- W3165377617 cites W2413218270 @default.
- W3165377617 cites W2415420071 @default.
- W3165377617 cites W2429184676 @default.
- W3165377617 cites W2485943928 @default.
- W3165377617 cites W2501096092 @default.
- W3165377617 cites W2508085917 @default.
- W3165377617 cites W2544356993 @default.
- W3165377617 cites W2559652202 @default.
- W3165377617 cites W2586582245 @default.
- W3165377617 cites W2590004183 @default.
- W3165377617 cites W2614612140 @default.
- W3165377617 cites W2765851545 @default.
- W3165377617 cites W2766241039 @default.
- W3165377617 cites W2776516714 @default.
- W3165377617 cites W2782208928 @default.
- W3165377617 cites W2785713700 @default.
- W3165377617 cites W2786376233 @default.
- W3165377617 cites W2793226438 @default.
- W3165377617 cites W2804191761 @default.
- W3165377617 cites W2804936066 @default.
- W3165377617 cites W2805661897 @default.
- W3165377617 cites W2806967266 @default.
- W3165377617 cites W2883316391 @default.
- W3165377617 cites W2897442673 @default.
- W3165377617 cites W2898582380 @default.
- W3165377617 cites W2902945171 @default.
- W3165377617 cites W2904836311 @default.
- W3165377617 cites W2909840109 @default.
- W3165377617 cites W2923573450 @default.
- W3165377617 cites W2935210822 @default.
- W3165377617 cites W2942799604 @default.
- W3165377617 cites W2943515929 @default.
- W3165377617 cites W2943685052 @default.
- W3165377617 cites W2947831096 @default.
- W3165377617 cites W2953891548 @default.
- W3165377617 cites W2954136099 @default.
- W3165377617 cites W2967642841 @default.